Cite
Treatment-free interval as an additional measure of efficacy in a large UK dataset of transplant ineligible myeloma patients.
MLA
Djebbari, Faouzi, et al. “Treatment-Free Interval as an Additional Measure of Efficacy in a Large UK Dataset of Transplant Ineligible Myeloma Patients.” PLoS ONE, vol. 15, no. 2, Feb. 2020, pp. 1–16. EBSCOhost, https://doi.org/10.1371/journal.pone.0229469.
APA
Djebbari, F., Sharpley, F. A., McLain-Smith, S., Vallance, G., Eyre, T. A., Kothari, J., Moore, S., & Ramasamy, K. (2020). Treatment-free interval as an additional measure of efficacy in a large UK dataset of transplant ineligible myeloma patients. PLoS ONE, 15(2), 1–16. https://doi.org/10.1371/journal.pone.0229469
Chicago
Djebbari, Faouzi, Faye A. Sharpley, Susan McLain-Smith, Grant Vallance, Toby A. Eyre, Jaimal Kothari, Sally Moore, and Karthik Ramasamy. 2020. “Treatment-Free Interval as an Additional Measure of Efficacy in a Large UK Dataset of Transplant Ineligible Myeloma Patients.” PLoS ONE 15 (2): 1–16. doi:10.1371/journal.pone.0229469.